Tempus AI

Last updated

Tempus AI is an American health technology company [1] founded in 2015 by Eric Lefkofsky in Chicago, Illinois. [2] It was established by Eric soon after his wife was diagnosed with breast cancer. [3] Tempus uses data and artificial intelligence to create precision medicine solutions, including diagnostics, [4] for oncology, cardiology, and depression. The company went public on June 14, 2024 [5] [6] under the ticker symbol "TEM."

Business Tempus is headquartered in Chicago, with offices in New York and San Francisco. It has three CAP/CLIA labs in Chicago, Atlanta, and Research Triangle Park. [7] Tempus does next-generation sequencing primarily for cancer patients, and pharmacogenomic testing for patients with depression.

Tempus investors include Baillie Gifford, New Enterprise Associates, Novo Holdings, Franklin Templeton Investments, Revolution LLC, Google LLC, etc. [8]

Related Research Articles

<span class="mw-page-title-main">Thomas Peterffy</span> Hungarian-American businessman (born 1944)

Thomas Peterffy is a Hungarian-born American billionaire businessman. He is the founder, chairman, and the largest shareholder of Interactive Brokers. Peterffy worked as an architectural draftsman after emigrating to the United States, and later became a computer programmer. In 1977, he purchased a seat on the American Stock Exchange and played a role in developing the first electronic trading platform for securities. As of March 2024, Forbes estimated his net worth at US$34.4 billion, making him the 46th richest man in the world.

<span class="mw-page-title-main">Eric Lefkofsky</span> American billionaire businessman (born 1969)

Eric Paul Lefkofsky is an American billionaire businessman. He is the founder of Tempus, and the co-founder of Groupon, Echo Global Logistics (ECHO), InnerWorkings (INWK), and Mediaocean. As of June 2024, he is also a co-managing partner of Chicago-based venture capital firm Lightbank. As of October 2021, his net worth was estimated at US$4.1 billion.

<span class="mw-page-title-main">Patrick Soon-Shiong</span> South African billionaire physician, CEO & philanthropist (b. 1952)

Patrick Soon-Shiong is a South African and American businessman, investor, medical researcher, philanthropist, and transplant surgeon. He is the inventor of the drug Abraxane, which became known for its efficacy against lung, breast, and pancreatic cancer. Soon-Shiong is the founder of NantWorks, a network of healthcare, biotech, and artificial intelligence startups; an adjunct professor of surgery and executive director of the Wireless Health Institute at the University of California, Los Angeles; and a visiting professor at Imperial College London and Dartmouth College. Soon-Shiong has published more than 100 scientific papers and has more than 230 issued patents worldwide on advancements spanning numerous fields in technology and medicine.

SurveyMonkey Inc. is an experience management company that offers cloud-based software in brand insights, market insights, product experience, employee experience, customer experience, online survey development, and a suite of paid back-end programs.

Lightspeed Venture Partners is a global venture capital firm focusing on seed stage, early stage investments and growth stage investments in the enterprise, fintech, consumer and healthcare sectors. Lightspeed has eleven offices globally and as of 2023 had approximately US$25 billion in assets under management.

<span class="mw-page-title-main">Docusign</span> American software company

Docusign, Inc. is an American software company headquartered in San Francisco, California, that provides products for organizations to manage electronic agreements with electronic signatures on different devices. As of 2024, Docusign has about 1.5 million clients in 180 countries. Signatures processed by Docusign are compliant with the US ESIGN Act and the European Union's eIDAS regulation, including EU Advanced and EU, Qualified Signatures.

Leon G. Cooperman is an American billionaire investor and hedge fund manager. He is the chairman and CEO of Omega Advisors, a New York-based investment advisory firm managing over $3.3 billion in assets under management, the majority consisting of his personal wealth.

<span class="mw-page-title-main">Virtu Financial</span> Financial services company

Virtu Financial is an American company that provides financial services, trading products and market making services. Virtu provides product suite including offerings in execution, liquidity sourcing, analytics, broker-neutral, multi-dealer platforms in workflow technology and two-sided quotations and trades in equities, commodities, currencies, options, fixed income, and other securities on over 230 exchanges, markets, and dark pools. Virtu uses proprietary technology to trade large volumes of securities. The company went public on the Nasdaq in 2015.

The technology company Facebook, Inc., held its initial public offering (IPO) on Friday, May 18, 2012. The IPO was one of the biggest in technology and Internet history, with a peak market capitalization of over $104 billion.

Bradley A. Keywell is an American billionaire entrepreneur. He is the founder and executive chairman of Uptake Technologies, an industrial AI software provider. He is an early investor of Tempus Labs, co-founder of Groupon, Echo Global Logistics, Mediaocean, DRIVIN, and Lightbank. He founded WNDR Museum and Chicago Ideas.

Tengion, Inc. is an American development-stage regenerative medicine company founded in 2003 with financing from J&J Development Corporation, HealthCap and Oak Investment Partners, which is headquartered in Winston-Salem, North Carolina. Its goals are discovering, developing, manufacturing and commercializing a range of replacement organs and tissues, or neo-organs and neo-tissues, to address unmet medical needs in urologic, renal, gastrointestinal, and vascular diseases and disorders. The company creates these human neo-organs from a patient’s own cells or autologous cells, in conjunction with its Organ Regeneration Platform.

<span class="mw-page-title-main">Interactive Brokers</span> American financial services firm

Interactive Brokers, Inc. (IB), headquartered in Greenwich, Connecticut, is an American multinational brokerage firm. It operates the largest electronic trading platform in the United States by number of daily average revenue trades - in 2023, it processed an average of 3 million trades per trading day. The company brokers stocks, options, futures contracts, EFPs, futures options, forex, bonds, mutual funds, and cryptocurrency. It offers omnibus and non-disclosed broker accounts and provides clearing services to 200 introducing brokers worldwide. It has operations in 34 countries and 27 currencies and has 2.6 million institutional and individual brokerage customers, with total customer equity of $426 billion as of December 31, 2023.

<span class="mw-page-title-main">UiPath</span> Romanian-American developer of robotic process automation software

UiPath Inc. is a global software company that makes robotic process automation (RPA) software. It was founded in Bucharest, Romania, by Daniel Dines and Marius Tîrcă. Its headquarters are in New York City. The company's software monitors user activity to automate repetitive front and back office tasks, including those performed using other business software such as customer relationship management or enterprise resource planning (ERP) software.

Qutoutiao is a Chinese mobile content aggregator.

<span class="mw-page-title-main">Eric Yuan</span> Chinese-American billionaire businessman

Eric S Yuan is a Chinese-American billionaire businessman, engineer, and the chief executive officer and founder of Zoom Video Communications, of which he owns 22%.

BeiGene, Ltd. is a China-based drug developer. It specializes in the development of drugs for cancer treatment. Founded in 2010 by chief executive officer John V. Oyler and Xiaodong Wang, the multinational company headquartered in Cambridge, Massachusetts has offices in North America, Europe, South America, Asia and Australia. BeiGene has a large presence in Chinese market. BeiGene has developed several pharmaceuticals, including tislelizumab, a checkpoint inhibitor, and zanubrutinib, a Bruton's tyrosine kinase inhibitor.

<span class="mw-page-title-main">R. J. Scaringe</span> American engineer and businessman (born 1983)

Robert "RJ" Scaringe is an American entrepreneur and engineer who founded and serves as CEO of electric vehicle manufacturer Rivian.

Amplitude, Inc. is an American publicly trading company that develops digital analytics software. The company was listed publicly on the Nasdaq stock exchange under the ticker symbol AMPL on September 28, 2021, at a market capitalization of $7.1 billion after its first day of trading.

C3.ai, Inc. is an American technology company specializing in enterprise artificial intelligence. Based in Redwood City, California, the company founded in 2009 by Thomas Siebel became a public company in 2020 and trades on the Nasdaq.

References

  1. ↑ "16. Tempus". CNBC . May 25, 2021.
  2. ↑ Rosenbaum, Leah (December 10, 2020). "EXCLUSIVE: Billionaire Eric Lefkofsky's Tempus Raises $200 Million to Bring Personalized Medicine to New Diseases". Forbes .
  3. ↑ Liu, Phoebe. "Billionaire Groupon Founder Eric Lefkofsky's Health Tech Company Goes Public—His Fourth IPO". Forbes. Retrieved June 20, 2024.
  4. ↑ Or, Amy (June 14, 2024). "Medical Data Firm Tempus AI Rises After $410.7 Million IPO". Bloomberg.
  5. ↑ de León, Riley (June 14, 2024). "Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut". CNBC .
  6. ↑ de León, Riley (June 14, 2024). "Google-backed Tempus AI closes first day of trading up 9% in Nasdaq stock market debut". CNBC .
  7. ↑ https://www.newsobserver.com/news/business/article253261478.html
  8. ↑ "SoftBank-backed Tempus AI seeks up to $6.1 bln valuation in US IPO". Reuters . June 5, 2024.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.